Yasunaga M - Search Results

1

Role of SLC6A6 in promoting the survival and multidrug resistance of colorectal cancer.

Yasunaga M, Matsumura Y. Yasunaga M, et al. Sci Rep. 2014 Apr 30;4:4852. doi: 10.1038/srep04852. Sci Rep. 2014. PMID: 24781822 Free PMC article.

2

Effect of combined treatment with micelle-incorporated cisplatin (NC-6004) and S-1 on human gastric cancer xenografts.

Kudo M, Yamamoto Y, Koga Y, Hamaguchi T, Akimoto T, Yasunaga M, Matsumura Y. Kudo M, et al. Among authors: yasunaga m. Mol Clin Oncol. 2016 Dec;5(6):817-822. doi: 10.3892/mco.2016.1070. Epub 2016 Nov 1. Mol Clin Oncol. 2016. PMID: 28101359 Free PMC article.

3

Preparation and characterization of anti-tissue factor single-chain variable fragment antibody for cancer diagnosis.

Sato R, Obonai T, Tsumura R, Tsumoto K, Koga Y, Yasunaga M, Matsumura Y. Sato R, et al. Among authors: yasunaga m. Cancer Sci. 2014 Dec;105(12):1631-7. doi: 10.1111/cas.12557. Epub 2014 Nov 20. Cancer Sci. 2014. PMID: 25311092 Free PMC article.

4

MicroRNA expression profiling of exfoliated colonocytes isolated from feces for colorectal cancer screening.

Koga Y, Yasunaga M, Takahashi A, Kuroda J, Moriya Y, Akasu T, Fujita S, Yamamoto S, Baba H, Matsumura Y. Koga Y, et al. Among authors: yasunaga m. Cancer Prev Res (Phila). 2010 Nov;3(11):1435-42. doi: 10.1158/1940-6207.CAPR-10-0036. Epub 2010 Oct 19. Cancer Prev Res (Phila). 2010. PMID: 20959518 Clinical Trial.

5

Significant antitumor effect of an antibody against TMEM180, a new colorectal cancer-specific molecule.

Yasunaga M, Saijou S, Hanaoka S, Anzai T, Tsumura R, Matsumura Y. Yasunaga M, et al. Cancer Sci. 2019 Feb;110(2):761-770. doi: 10.1111/cas.13907. Epub 2019 Jan 4. Cancer Sci. 2019. PMID: 30537002 Free PMC article.

6

Collagen type I induces EGFR-TKI resistance in EGFR-mutated cancer cells by mTOR activation through Akt-independent pathway.

Yamazaki S, Higuchi Y, Ishibashi M, Hashimoto H, Yasunaga M, Matsumura Y, Tsuchihara K, Tsuboi M, Goto K, Ochiai A, Ishii G. Yamazaki S, et al. Among authors: yasunaga m. Cancer Sci. 2018 Jun;109(6):2063-2073. doi: 10.1111/cas.13624. Cancer Sci. 2018. PMID: 29701925 Free PMC article.

7

Antitumor effect of antitissue factor antibody-MMAE conjugate in human pancreatic tumor xenografts.

Koga Y, Manabe S, Aihara Y, Sato R, Tsumura R, Iwafuji H, Furuya F, Fuchigami H, Fujiwara Y, Hisada Y, Yamamoto Y, Yasunaga M, Matsumura Y. Koga Y, et al. Among authors: yasunaga m. Int J Cancer. 2015 Sep 15;137(6):1457-66. doi: 10.1002/ijc.29492. Epub 2015 Mar 9. Int J Cancer. 2015. PMID: 25704403 Free PMC article.

8

Effect of combined treatment with the epirubicin-incorporating micelles (NC-6300) and 1,2-diaminocyclohexane platinum (II)-incorporating micelles (NC-4016) on a human gastric cancer model.

Yamamoto Y, Hyodo I, Takigahira M, Koga Y, Yasunaga M, Harada M, Hayashi T, Kato Y, Matsumura Y. Yamamoto Y, et al. Among authors: yasunaga m. Int J Cancer. 2014 Jul 1;135(1):214-23. doi: 10.1002/ijc.28651. Epub 2013 Dec 18. Int J Cancer. 2014. PMID: 24353132

9

Tailored immunoconjugate therapy depending on a quantity of tumor stroma.

Yasunaga M, Manabe S, Tarin D, Matsumura Y. Yasunaga M, et al. Cancer Sci. 2013 Feb;104(2):231-7. doi: 10.1111/cas.12062. Epub 2012 Dec 16. Cancer Sci. 2013. PMID: 23121194 Free PMC article.

10

Cancer-stroma targeting therapy by cytotoxic immunoconjugate bound to the collagen 4 network in the tumor tissue.

Yasunaga M, Manabe S, Tarin D, Matsumura Y. Yasunaga M, et al. Bioconjug Chem. 2011 Sep 21;22(9):1776-83. doi: 10.1021/bc200158j. Epub 2011 Aug 4. Bioconjug Chem. 2011. PMID: 21749132

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results